Neurocrine Biosciences (NBIX) Tops Q2 EPS by 44c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $152.56 +1.15%
Financial Fact:
Research and development: 20.94M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 20.94M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of $1.25, $0.44 better than the analyst estimate of $0.81. Revenue for the quarter came in at $452.7 million versus the consensus estimate of $446.75 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
